Survey of ophthalmology最新文献

筛选
英文 中文
Structural en face optical coherence tomography in neovascular and nonneovascularage-related macular degeneration: Use and utility in clinical practice 新生血管和非新生血管相关黄斑变性的结构性面光相干断层扫描:临床实践中的使用和效用。
IF 5.1 2区 医学
Survey of ophthalmology Pub Date : 2024-11-09 DOI: 10.1016/j.survophthal.2024.11.003
Clara Rizzo MD , Maria Cristina Savastano MD , Raphael Kilian MD , Giorgio Marchini MD , Stanislao Rizzo MD
{"title":"Structural en face optical coherence tomography in neovascular and nonneovascularage-related macular degeneration: Use and utility in clinical practice","authors":"Clara Rizzo MD ,&nbsp;Maria Cristina Savastano MD ,&nbsp;Raphael Kilian MD ,&nbsp;Giorgio Marchini MD ,&nbsp;Stanislao Rizzo MD","doi":"10.1016/j.survophthal.2024.11.003","DOIUrl":"10.1016/j.survophthal.2024.11.003","url":null,"abstract":"<div><div>Age-related macular degeneration (AMD) is a leading cause of blindness and visual impairment worldwide. Structural <em>en face</em> optical coherence tomography (OCT) is an innovative imaging technology that has recently attracted interest because of its potential for assessing AMD features. We conducted a comprehensive review of its application in AMD. In neovascular AMD, structural <em>en face</em> OCT can detect exudative activity, monitor the neovascularization area, study the choroid in polypoidal choroidal vasculopathy, and visualize neovascular membranes in pigment epithelial detachments. Moreover, in nonneovascular AMD, this study provides details on geographic atrophy and drusen, the identification of intraretinal retinal pigment epithelium migration, and the detection of different patterns of outer retinal tubulations. Our study revealed that structural <em>en face</em> OCT can provide relevant information on patients with AMD.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 4","pages":"Pages 725-733"},"PeriodicalIF":5.1,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heavy duty 重型。
IF 5.1 2区 医学
Survey of ophthalmology Pub Date : 2024-11-08 DOI: 10.1016/j.survophthal.2024.11.001
M. Tariq Bhatti , Darron H. Fors , Irma Muminovic , Shira L. Robbins
{"title":"Heavy duty","authors":"M. Tariq Bhatti ,&nbsp;Darron H. Fors ,&nbsp;Irma Muminovic ,&nbsp;Shira L. Robbins","doi":"10.1016/j.survophthal.2024.11.001","DOIUrl":"10.1016/j.survophthal.2024.11.001","url":null,"abstract":"<div><div>A 54-year-old woman with myopia, hypothyroidism, and asthma presented with intermittent double vision. Serum was positive for anti-low density lipoprotein receptor-related protein 4 (LRP4) antibodies suggesting the diagnosis of myasthenia gravis. There was no improvement with pyridostigmine, prednisone, or azathioprine. Over time her double vision became constant, and she was noted to have mild limitation of abduction in both eyes with an esotropia, left hypotropia, and excyclotorsion. Magnetic resonance imaging showed nasal displacement of the superior rectus and inferior rectus muscles, inferior displacement of the lateral rectus muscles and superotemporal globe prolapse consistent with heavy eye syndrome (HES). The differential diagnosis, clinical and radiological manifestations of HES are discussed.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 2","pages":"Pages 352-355"},"PeriodicalIF":5.1,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The secondary childhood glaucomas 继发性儿童青光眼。
IF 5.1 2区 医学
Survey of ophthalmology Pub Date : 2024-10-31 DOI: 10.1016/j.survophthal.2024.10.005
Maram EA Abdalla Elsayed , Beatrice Lander , Sirisha Senthil , Deepak P. Edward , Rizwan Malik
{"title":"The secondary childhood glaucomas","authors":"Maram EA Abdalla Elsayed ,&nbsp;Beatrice Lander ,&nbsp;Sirisha Senthil ,&nbsp;Deepak P. Edward ,&nbsp;Rizwan Malik","doi":"10.1016/j.survophthal.2024.10.005","DOIUrl":"10.1016/j.survophthal.2024.10.005","url":null,"abstract":"<div><div>The secondary childhood glaucomas are a heterogenous group, often associated with other ocular or systemic abnormalities. These childhood glaucomas are distinct from primary childhood glaucomas, both in terms of their clinical features and their response to conventional treatment. Surgical management can be challenging in children with secondary glaucoma. On average, this group undergo more surgical procedures and revisions than those with primary congenital glaucoma. We provide a synopsis of secondary childhood glaucomas in terms of classification, clinical features, and management strategies, with emphasis on recent developments.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 3","pages":"Pages 544-562"},"PeriodicalIF":5.1,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choroidal biomarkers in age-related macular degeneration 老年性黄斑变性的脉络膜生物标志物。
IF 5.1 2区 医学
Survey of ophthalmology Pub Date : 2024-10-18 DOI: 10.1016/j.survophthal.2024.10.004
Elham Sadeghi MD , Nicola Valsecchi MD , Elham Rahmanipour MD , Mahsa Ejlalidiz MD , Nasiq Hasan MD , Kiran Kumar Vupparaboina PhD , Mohammed Nasar Ibrahim PhD , Mohammed Abdul Rasheed , Jiwon Baek , Danilo Iannetta MD , Jay Chhablani MD
{"title":"Choroidal biomarkers in age-related macular degeneration","authors":"Elham Sadeghi MD ,&nbsp;Nicola Valsecchi MD ,&nbsp;Elham Rahmanipour MD ,&nbsp;Mahsa Ejlalidiz MD ,&nbsp;Nasiq Hasan MD ,&nbsp;Kiran Kumar Vupparaboina PhD ,&nbsp;Mohammed Nasar Ibrahim PhD ,&nbsp;Mohammed Abdul Rasheed ,&nbsp;Jiwon Baek ,&nbsp;Danilo Iannetta MD ,&nbsp;Jay Chhablani MD","doi":"10.1016/j.survophthal.2024.10.004","DOIUrl":"10.1016/j.survophthal.2024.10.004","url":null,"abstract":"<div><div>Age-related macular degeneration (AMD) is the leading cause of central visual impairment in the elderly. The exact pathophysiological mechanisms for AMD remain uncertain. Several studies suggest that choroidal abnormalities and alterations are critical in AMD progression. The transition from manual to automated segmentation and binarization techniques has resulted in accurate and precise measurements of different choroidal parameters. These qualitative and quantitative parameters, known as choroidal imaging biomarkers, have advanced from basic vertical subfoveal choroidal thickness to more intricate 3-dimensional choroidal reconstruction methods in the last decade. Therefore, a comprehensive evaluation of choroidal metrics may investigate valuable insights into AMD, potentially guiding the future development of customized therapeutic strategies and personalized patient care in AMD management. We describe the role of different choroidal biomarkers in evaluating patients with AMD and their contribution to management.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 2","pages":"Pages 167-183"},"PeriodicalIF":5.1,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vision degrading myodesopsia from vitreous floaters in the young: An important aspect of myopia 青少年玻璃体漂浮物引起的视力退化性近视:近视的一个重要方面
IF 5.1 2区 医学
Survey of ophthalmology Pub Date : 2024-10-16 DOI: 10.1016/j.survophthal.2024.10.001
Michael Albrecht, Gerd U. Auffarth, Maximilian Friedrich, Lucy J. Kessler, Ramin Khoramnia
{"title":"Vision degrading myodesopsia from vitreous floaters in the young: An important aspect of myopia","authors":"Michael Albrecht,&nbsp;Gerd U. Auffarth,&nbsp;Maximilian Friedrich,&nbsp;Lucy J. Kessler,&nbsp;Ramin Khoramnia","doi":"10.1016/j.survophthal.2024.10.001","DOIUrl":"10.1016/j.survophthal.2024.10.001","url":null,"abstract":"<div><div>Vitreous floaters are visual phenomena resulting from floating opacities inside the eye that disturb vision. The opacities consist of microscopic collagen fibers that aggregate in myopia and during aging. These collagen fibers are then seen as irregular, sometimes worm-like shadows or structures of a translucent to black color. Because of the floating aspect, they tend to follow the movements of the eye, causing distress and having a negative impact on a patient’s quality of life due to degradation in contrast sensitivity function. This is referred to as vision degrading myodesopsia (VDM). The overall importance of floaters and their effect on quality of life gained attention in recent years. While the existence of floaters alone is labeled as harmless, there is an increasing group of young people suffering from VDM. This coincides with the growing prevalence of myopia. Indeed, myopia and myopic vitreopathy are the major causes of VDM in the young. This aspect of myopia, however, is often overlooked. We review the current research status in floater formation, quality of life impact, symptom assessment, localization and therapeutic options for vitreous floaters from the perspective of a myopic, potentially younger patient group.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 2","pages":"Pages 265-282"},"PeriodicalIF":5.1,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analysis of treatment outcomes for patients with m.11778G>A MT-ND4 Leber hereditary optic neuropathy m.11778G>A MT-ND4 Leber 遗传性视神经病变患者治疗效果的元分析。
IF 5.1 2区 医学
Survey of ophthalmology Pub Date : 2024-10-16 DOI: 10.1016/j.survophthal.2024.10.002
Nancy J. Newman MD , Valérie Biousse MD , Patrick Yu-Wai-Man MD, PhD , Valerio Carelli MD, PhD , Catherine Vignal-Clermont MD , François Montestruc MSc , Magali Taiel MD , José-Alain Sahel MD, PhD
{"title":"Meta-analysis of treatment outcomes for patients with m.11778G>A MT-ND4 Leber hereditary optic neuropathy","authors":"Nancy J. Newman MD ,&nbsp;Valérie Biousse MD ,&nbsp;Patrick Yu-Wai-Man MD, PhD ,&nbsp;Valerio Carelli MD, PhD ,&nbsp;Catherine Vignal-Clermont MD ,&nbsp;François Montestruc MSc ,&nbsp;Magali Taiel MD ,&nbsp;José-Alain Sahel MD, PhD","doi":"10.1016/j.survophthal.2024.10.002","DOIUrl":"10.1016/j.survophthal.2024.10.002","url":null,"abstract":"<div><div>Our aim was to assess the visual outcomes of patients with Leber hereditary optic neuropathy (LHON) harboring the m.11778G&gt;A <em>MT-ND4</em> mutation who had no treatment (natural history) or received idebenone or lenadogene nolparvovec. Efficacy outcomes included clinically relevant recovery (CRR) from nadir and final best-corrected visual acuity (BCVA). For the natural history and idebenone groups, we performed a systematic review of the literature and available clinical/regulatory reports. For the lenadogene nolparvovec group, all data from phase 3 studies were included. The overall effect and its 95 % confidence interval (CI) were estimated using a random effects model. For each meta-analysis, patients had a mean age of approximately 30 years at vision loss and were mostly (≥78 %) men. The CRR from nadir [95 % CI] at eye level was 17 % [7 %; 30 %] (n=316 eyes), 31 % [24 %; 40 %] (n=313) and 59 % [54 %; 64 %] (n=348) in untreated, idebenone-treated and lenadogene nolparvovec-treated patients, respectively. This gradient of efficacy was also observed with CRR at the patient level and final BCVA. There was a gradient of efficacy in all assessed visual outcomes, more marked for CRR than for final BCVA, with lenadogene nolparvovec gene therapy superior to idebenone treatment, and both superior to the natural history of the disease.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 2","pages":"Pages 283-295"},"PeriodicalIF":5.1,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric keratoconus 小儿角膜炎
IF 5.1 2区 医学
Survey of ophthalmology Pub Date : 2024-10-12 DOI: 10.1016/j.survophthal.2024.10.003
Yogita Gupta , Chandradevi Shanmugam , Priyadarshini K , Sohini Mandal , Radhika Tandon , Namrata Sharma
{"title":"Pediatric keratoconus","authors":"Yogita Gupta ,&nbsp;Chandradevi Shanmugam ,&nbsp;Priyadarshini K ,&nbsp;Sohini Mandal ,&nbsp;Radhika Tandon ,&nbsp;Namrata Sharma","doi":"10.1016/j.survophthal.2024.10.003","DOIUrl":"10.1016/j.survophthal.2024.10.003","url":null,"abstract":"<div><div>Keratoconus is a common pediatric corneal disease, leading to vision impairment and amblyopia. Compared to its adult counterpart, pediatric keratoconus has an advanced presentation, rapid progression, higher incidence of complications such as corneal hydrops, and greater potential impact on the quality of life. It typically manifests during puberty and can evolve rapidly to more severe stages if left untreated. This rapid progression underscores the importance of early diagnosis through regular screening in pediatric populations and vigilant monitoring of pediatric keratoconus suspects. Concomitant ocular allergies, ocular anomalies, systemic diseases (e.g. syndromes), and poor compliance with contact lenses might impede prompt intervention and frequently postpone rehabilitation. Corneal collagen crosslinking is a crucial intervention in the management of pediatric keratoconus because it strengthens the corneal microstructure and halts the disease progression. When conservative measures fail, keratoplasty remains a viable option with generally favorable outcomes, though with unique challenges in post-operative care, including concerns related to sutures, long-term graft survival and need for repeated examinations under anesthesia. A multidisciplinary approach involving ophthalmologists, optometrists, pediatricians, and other healthcare professionals, focusing on early diagnosis and timely intervention, is essential for the comprehensive management of pediatric keratoconus and to mitigate its impact on children's lives.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 2","pages":"Pages 296-330"},"PeriodicalIF":5.1,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choroidal thickness after anti-vascular endothelial growth factor in typical neovascular age-related macular degeneration – A systematic review and meta-analysis 抗血管内皮生长因子治疗典型新生血管性老年性黄斑变性后的脉络膜厚度 - 系统回顾和荟萃分析。
IF 5.1 2区 医学
Survey of ophthalmology Pub Date : 2024-10-05 DOI: 10.1016/j.survophthal.2024.09.011
Erlend Hoven MD , John-Thomas Michelet MD , Mario V. Vettore PhD , Neil Lagali PhD
{"title":"Choroidal thickness after anti-vascular endothelial growth factor in typical neovascular age-related macular degeneration – A systematic review and meta-analysis","authors":"Erlend Hoven MD ,&nbsp;John-Thomas Michelet MD ,&nbsp;Mario V. Vettore PhD ,&nbsp;Neil Lagali PhD","doi":"10.1016/j.survophthal.2024.09.011","DOIUrl":"10.1016/j.survophthal.2024.09.011","url":null,"abstract":"<div><div>Age-related macular degeneration (AMD) is one of the leading causes of blindness in the world and anti-vascular endothelial growth factor (VEGF) injections have been the standard of care for the wet/neovascular variant since 2004. Currently, there are conflicting reports regarding its effect on the choroid, which supplies outer retina with oxygen and other nutrients. We synthesize available information of anti-VEGF on choroidal thickness (CT) in treatment-naïve typical neovascular AMD patients during the initial 12-week loading phase. We found 43 studies involving 1901 eyes from 1878 patients were included. Meta-analysis of 35 studies reporting CT at baseline and after 12 weeks suggested a significant decrease in CT with anti-VEGF treatment. A greater mean change with aflibercept compared to ranibizumab was found in subgroup analyses of sub-foveal CT in types 1 and 2 macular neovascularization. The long-term consequences of reduced CT in neovascular AMD remain unclear and require further targeted studies.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 1","pages":"Pages 86-95"},"PeriodicalIF":5.1,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142393523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence and risk factors of perioperative suprachoroidal hemorrhage: A systematic review and meta-analysis 围手术期脉络膜上腔出血的发生率和风险因素:系统回顾和荟萃分析。
IF 5.1 2区 医学
Survey of ophthalmology Pub Date : 2024-10-03 DOI: 10.1016/j.survophthal.2024.09.009
Tianyu Liu , Ayman G. Elnahry , Zujaja Tauqeer , Yinxi Yu , Gui-shuang Ying , Benjamin J. Kim
{"title":"Incidence and risk factors of perioperative suprachoroidal hemorrhage: A systematic review and meta-analysis","authors":"Tianyu Liu ,&nbsp;Ayman G. Elnahry ,&nbsp;Zujaja Tauqeer ,&nbsp;Yinxi Yu ,&nbsp;Gui-shuang Ying ,&nbsp;Benjamin J. Kim","doi":"10.1016/j.survophthal.2024.09.009","DOIUrl":"10.1016/j.survophthal.2024.09.009","url":null,"abstract":"<div><div>Suprachoroidal hemorrhage (SCH) is a potentially visually devastating complication of intraocular surgery, but estimates of perioperative SCH incidence vary. We performed a systematic review and meta-analysis of perioperative SCH incidence among population-based studies published between 1990 and 2023. Thirty-five studies collectively reported 1657 cases of perioperative SCH from a population of 3,028,911 surgeries. The estimated incidence of SCH was 0.12 % (95 % CI, 0.10–0.14 %), or about 1 in every 800 surgeries. The estimated incidence of perioperative massive SCH was 0.06 % (95 % CI, 0.04–0.08 %). In multivariable meta-regression, greater SCH incidence was significantly associated with smaller study population size, comparative study design, multicenter study setting, and intraoperative or delayed SCH timing (vs intraoperative alone), while lower SCH incidence was significantly associated with vitreoretinal or mixed surgery type (vs. cataract) (all P &lt; 0.05). Study year was not a significant predictor of SCH incidence, suggesting that the incidence of SCH has not decreased over the past 3 decades despite improvements in surgical technologies and techniques. Given the rarity of SCH, and the strong effect of study population size on reported SCH incidence rates, future studies of SCH incidence should include a minimum population size of at least 1000 surgeries to obtain an accurate estimate of SCH incidence.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 1","pages":"Pages 54-62"},"PeriodicalIF":5.1,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breaking the barriers: Methodology of implementation of a non-mydriatic ocular fundus camera in an emergency department 打破障碍:在急诊科使用非眼球震颤眼底照相机的方法。
IF 5.1 2区 医学
Survey of ophthalmology Pub Date : 2024-09-30 DOI: 10.1016/j.survophthal.2024.09.012
Gabriele Berman MD , Andrew M. Pendley MD , David W. Wright MD , Rachel Silverman BA , Chris Kelley BA , Mariana Rodriguez Duran BSA , Mariam Torres Soto BA, MA , Nithya Shanmugam BA , Matthew Keadey MD , Nancy J. Newman MD , Valérie Biousse MD
{"title":"Breaking the barriers: Methodology of implementation of a non-mydriatic ocular fundus camera in an emergency department","authors":"Gabriele Berman MD ,&nbsp;Andrew M. Pendley MD ,&nbsp;David W. Wright MD ,&nbsp;Rachel Silverman BA ,&nbsp;Chris Kelley BA ,&nbsp;Mariana Rodriguez Duran BSA ,&nbsp;Mariam Torres Soto BA, MA ,&nbsp;Nithya Shanmugam BA ,&nbsp;Matthew Keadey MD ,&nbsp;Nancy J. Newman MD ,&nbsp;Valérie Biousse MD","doi":"10.1016/j.survophthal.2024.09.012","DOIUrl":"10.1016/j.survophthal.2024.09.012","url":null,"abstract":"<div><div>Despite evidence that non-mydriatic fundus cameras are beneficial in non-ophthalmic settings, they are only available in a minority of hospitals in the US. The lag from research-based evidence to change in clinical practice highlights the complexities of implementation of new technology and practice. We describe the steps used to implement successfully a non-mydriatic ocular fundus camera combined with optical coherence tomography (OCT) in a general emergency department (ED) using Kotter’s 8-Step Change Model. We prospectively collected the number of trained personnel in the ED, the number of imaging studies obtained each week during the first year following implementation, and we documented major achievements each month, as well as outcome measures, barriers to implementation and possible solutions. Between 12 and 42 patients were imaged per week, resulting in a total of 1274 patients imaged demonstrating sustained usage of non-mydriatic fundus camera/OCT in the ED one year after implementation. The implementation process was contingent upon multidisciplinary collaboration, extensive communication, coordinated training of staff, and continuous motivation. The future will likely include the use of artificial intelligence deep learning systems for automated interpretation of ocular imaging as an immediate diagnostic aid for ED or other non-eye care providers.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 1","pages":"Pages 153-161"},"PeriodicalIF":5.1,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142366611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信